文献速递类风湿关节炎

牙周治疗对类风湿关节炎患者疗效的循证研究:系统综述与Meta分析

Evidence-Based Research on Effectiveness of Periodontal Treatment in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-07-12

该系统综述与Meta分析检索了随机试验和对照队列研究,评估牙周治疗对类风湿关节炎(RA)患者疾病活动度和全身炎症负荷的影响。共纳入9项研究(10个比较,n=388),结果显示牙周治疗对疾病活动度有有利影响(SMD -0.88,95%CI -1.38至-0.38;n=311),但证据确定性为低或极低。作者认为需要设计严谨的前瞻性队列研究(优选随机对照试验)进一步验证。

要点

  • 牙周治疗可能改善RA患者的疾病活动度(SMD -0.88),但证据确定性低。
  • 纳入研究存在选择偏倚和RA用药稳定性差异导致的异质性。
  • 亟需严谨设计的前瞻性研究(优选RCT)验证牙周治疗在RA中的疗效。

核心结论

  • 牙周治疗对RA患者疾病活动度显示出有利影响,但证据确定性为低或极低,可能随更多证据而改变。
  • 目前亟需设计严谨的前瞻性队列研究(优选随机对照试验)来确认牙周治疗在RA中的疗效。

研究设计与样本

  • 检索PubMed、Cochrane Library(CENTRAL)、Embase、ClinicalTrials.gov和WHO ICTRP,纳入随机试验和对照队列研究。
  • 最终纳入9项研究(10个比较,n=388)进行定量合成,使用OMERACT认可的RA试验结局域。
  • 采用随机效应模型合并标准化均数差(SMD)及95%置信区间(95%CI),用I2统计量评估不一致性,固定效应模型用于敏感性分析。

主要发现

  • 在1909项已识别研究中,9项(10个比较,n=388)符合定量合成条件。
  • 牙周治疗对疾病活动度有有利影响(SMD -0.88 [95% CI -1.38, -0.38];n=311)。
  • 选择偏倚和RA用药稳定性被强调为研究间异质性的来源。

关键数值与推荐

  • 采用GRADE方法评判证据确定性,评级为低或极低确定性。
  • 使用SMD及95%CI汇总连续结局,随机效应模型用于Meta分析,固定效应模型用于敏感性分析。
  • 采用I2统计量评估不一致性,并进行了分层/元回归分析以探索异质性(以T2表示)。

临床怎么用

  • 牙周治疗可能作为RA患者疾病活动度管理的辅助措施,但需结合低确定性证据谨慎解读。
  • 临床决策时应考虑研究间异质性来源(如选择偏倚和RA用药稳定性)对结果的影响。

局限性

  • 证据确定性被评为低或极低,任何可能效应随更多证据提供而可能改变。
  • 研究间存在异质性,选择偏倚和RA用药稳定性是突出来源。
  • 缺乏设计严谨、标准化诊断标准和足够随访时间的前瞻性研究(优选RCT)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To gauge the evidence of periodontal therapy's impact on measures of disease activity and systemic inflammatory burden in individuals with rheumatoid arthritis (RA). METHODS: A search for randomized trials and controlled cohort studies of RA patients with periodontitis was conducted on April 7, 2019, with an update on December 17, 2020 in PubMed, Cochrane Library (CENTRAL), Embase, ClinicalTrials.gov, and the World Health Organization International Clinical Trial Registry Platform portal. Two reviewers screened titles and abstracts and selected papers for full-text review. We used Outcome Measures in Rheumatology (OMERACT)-endorsed outcome domains for RA trials and summarized continuous outcomes using standardized mean differences (SMDs) with 95% confidence intervals (95% CIs). We evaluated inconsistency using the I2 statistic and combined SMDs using random-effects models for the meta-analyses; fixed-effect meta-analyses were used for sensitivity analysis. To explore heterogeneity, we added stratified/meta-regression analyses, expressed in T2 . RESULTS: Of the 1,909 studies identified, 9 (including 10 comparisons) were eligible for quantitative synthesis (n = 388). Evidence suggested a favorable effect of periodontal treatment on disease activity (SMD -0.88 [95% CI -1.38, -0.38]; n = 311). The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to judge the estimates' certainty; evidence rated as having low or very low certainty indicated that any possible effect of periodontal treatment in RA is likely to change as more evidence is provided. Selection bias and RA medication stability were highlighted as sources of heterogeneity between studies. CONCLUSION: There is an urgent need for a well-designed prospective cohort study (preferably a randomized controlled trial) of patients with RA and periodontitis using rigorous protocols, standardized diagnostic criteria, data collection, and adequate duration of follow-up.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Silva DS, Costa F, Baptista IP, et al. Evidence-Based Research on Effectiveness of Periodontal Treatment in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. Arthritis Care Res (Hoboken). 2022. PMID: 33973383. doi:10.1002/acr.24622

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。